Abstract:OBJECTIVETo investigate the effect of propofol on the activation of nuclear factor-kappa B (NF-kappa B) and the expression of inflammatory cytokines, such as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and intercellular adhesion molecule-1 (ICAM-1) in cerebral cortex during transient focal cerebral ischemia-reperfusion, and to discuss the probable mechanism of its protective effect.METHODSNinety male Wistar rats were randomly divided into 3 equal groups: sham operation group undergoing sham operation; ischemia/reperfusion (I/R) group undergoing thread embolism of the left middle cerebral artery occlusion (MCAO) to cause focal ischemia for 2 hours and then undergoing reperfusion; and propofol group undergoing peritoneal injection of propofol 2 hours before the ischemia-reperfusion of MCAO. Then the rats in the 3 groups were re-divided into subgroups of 5 rats, totally 18 subgroups, to be decapitated 2, 3, 6, 12, 24, and 72 hours after reperfusion for the latter 2 groups, and their brains were taken out and fixed. Immunohistochemistry was used to detect the translocation of NF-kappaB in the neurons and the expression of IL-1, TNF-alpha, and ICAM-1 in the brain. Western blotting was used to detect the expression of NF-kappa B. The opposite non-ischemic cortexes were used as controls.RESULTSTwo to 24 hours after the reperfusion NF-kappaB was significantly translocated from the cytoplasm into the nucleus; however, NF-kappa B remained in the cytoplasm of bilateral cortexes in the sham operation groups, and the nonischemic cortexes in the I/R and protofol groups. The translocation of NF-kappa B from cytoplasm into nucleus was significantly inhibited in the ischemic cortex of the propofol group. The expression values of NF-kappa B in the nuclei of ischemic cortexes in the I/R group 2 to 24 hours after reperfusion were significantly higher than those in the sham operation group and the nonischemic cortexes of the I/R and propofol groups (all P < 0.01). The expression values of NF-kappa B in the ischemic cortex of the propofol group 2 to 24 hours after reperfusion was significantly lower than that of the I/R group (all P < 0.05). The expression values of IL-1, TNF-alpha, and ICAM-1 in the ischemic cortexes were significantly higher than that in the cortex of the sham operation group and those in the nonischemic cortexes of the I/R group and propofol group (P < 0.01 or P < 0.05) and the expression values of IL-1, TNF-alpha, and ICAM-1 in the propofol group were all significantly lower than those in the I/R group (all P < 0.05).CONCLUSIONPropofol inhibits the inflammatory reaction by inhibiting the NF-kappa B activation during focal ischemia-reperfusion which may be one of the mechanisms of its neuroprotective function.

Propofol Attenuates Intermittent Hypoxia Induced Up-Regulation of Proinflammatory Cytokines in Microglia Through Inhibiting the Activation of NF-Bκ/p38 MAPK Signalling.

Propofol Inhibits Microglial Activation Via Mir-106B/pi3k/akt Axis.

Propofol Reduces Microglia Activation and Neurotoxicity Through Inhibition of Extracellular Vesicle Release

Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling

Propofol Attenuates Inflammatory Response in LPS-Activated Microglia by Regulating the miR-155/SOCS1 Pathway

Posttreatment with propofol attenuates lipopolysaccharide-induced up-regulation of inflammatory molecules in primary microglia

Delayed Treatment of Propofol Inhibits Lipopolysaccharide-Induced Inflammation in Microglia Through the PI3K/PKB Pathway.

Propofol inhibits neuroinflammation and metabolic reprogramming in microglia in vitro and in vivo

Effect of Propofol on Mucous Permeability and Inflammatory Mediators Expression in the Intestine Following Traumatic Brain Injury in Rats

Propofol Ameliorates Microglia Activation by Targeting MicroRNA-221/222-IRF2 Axis

Intracellular Ca2+ Homeostasis And Jak1/Stat3 Pathway Are Involved In The Protective Effect Of Propofol On Bv2 Microglia Against Hypoxia-Induced Inflammation And Apoptosis

Propofol Pretreatment Prevents Oxygen-Glucose Deprivation/Reoxygenation (OGD/R)-induced Inflammation Through Nuclear Transcription Factor κB (NF-κB) Pathway in Neuroblastoma Cells

Propofol inhibits the activation of p38 through up-regulating the expression of annexin A1 to exert its anti-inflammation effect

Propofol Attenuates Inflammatory Damage <i>via</i> Inhibiting NLRP1-Casp1-Casp6 Signaling in Ischemic Brain Injury

Propofol Protects Against TNF-α-induced Blood-brain Barrier Disruption via the PIM-1/eNOS/NO Pathway

Propofol maintains Th17/Treg cell balance and reduces inflammation in rats with traumatic brain injury via the miR‑145‑3p/NFATc2/NF‑κB axis

The protective effect of propofol against TNF-α-induced apoptosis was mediated via inhibiting iNOS/NO production and maintaining intracellular Ca 2+ homeostasis in mouse hippocampal HT22 cells.

Inhibition of Microglial Activation Contributes to Propofol-Induced Protection Against Post-Cardiac Arrest Brain Injury in Rats

[Effect of Propofol on the Activation of Nuclear Factor-Kappa B and Expression of Inflammatory Cytokines in Cerebral Cortex During Transient Focal Cerebral Ischemia-Reperfusion: Experiment with Rats].

Propofol Reduces Inflammatory Brain Injury after Subarachnoid Hemorrhage: Involvement of PI3K/Akt Pathway

Propofol Prevents Cerebral Ischemia-Triggered Autophagy Activation and Cell Death in the Rat Hippocampus Through the NF-κB/p53 Signaling Pathway